Axsome Therapeutics (AXSM) Assets Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.40% |
| Dec 31, 2025 | 27.67% |
| Sep 30, 2025 | 25.45% |
| Jun 30, 2025 | 52.45% |
| Mar 31, 2025 | 88.87% |
| Dec 31, 2024 | 86.40% |
| Sep 30, 2024 | 68.87% |
| Jun 30, 2024 | 56.41% |
| Mar 31, 2024 | 48.42% |
| Dec 31, 2023 | 46.75% |
| Sep 30, 2023 | 43.43% |
| Jun 30, 2023 | 47.40% |
| Mar 31, 2023 | 25.31% |
| Dec 31, 2022 | 14.55% |
| Sep 30, 2022 | 96.85% |
| Jun 30, 2022 | 48.82% |
| Mar 31, 2022 | 26.35% |
| Dec 31, 2021 | 78.72% |
| Sep 30, 2021 | 93.37% |
| Jun 30, 2021 | 87.52% |
| Mar 31, 2021 | 81.45% |
| Dec 31, 2020 | 73.64% |
| Sep 30, 2020 | 84.13% |
| Jun 30, 2020 | 69.76% |
| Mar 31, 2020 | 62.13% |
| Dec 31, 2019 | 79.38% |
| Sep 30, 2019 | 8.37% |
| Jun 30, 2019 | 11.04% |
| Mar 31, 2019 | -0.93% |
| Dec 31, 2018 | -32.08% |